Gnosis Health

Investor: Innovate UK, SFC Capital, Northstar Ventures

Gnosis Health, a spinout from Newcastle and Plymouth universities, has successfully secured £1.1 million in a recent funding round. This capital infusion is earmarked to advance the development and market launch of MAXine, its innovative AI-powered digital healthcare assistant specifically designed for Parkinson's disease management.Summary of transaction details:Value: £1.1 millionSector: Healthcare & BiotechAdvisor: Not mentionedKey Entities: Target: Gnosis Health; Investors: Innovate UK, SFC Capital, Northstar VenturesLocation: UK (implied by Newcastle/Plymouth universities, Innovate UK, North East NHS pilots)Note: This funding round will enable Gnosis Health to expand its engineering capabilities, complete critical NHS pilots, and accelerate the commercial debut of MAXine, addressing a significant clinical need for continuous, adaptive monitoring in Parkinson's care through advanced AI and wearable integration.